Last updated on March 2018

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Fetal Growth Retardation | Pre-Eclampsia | Fetal Death | Abruptio Placentae | HELLP Syndrome | Antenatal | Eclampsia
  • Age: Between 18 - 100 Years
  • Gender: Female

Inclusion Criteria:

  • pregnant woman with a diagnosis of placental vascular disease (gestational hypertension, preeclampsia, IUGR)

Exclusion Criteria:

  • patient who refuses the obstetric follow-up

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.